eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/iovs.12-9797PMID 22930723PMCID PMC3466063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy.

  2010cited by this paper
• Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells.

  2010cited by this paper
• Nox2-Containing NADPH Oxidase Deficiency Confers Protection From Hindlimb Ischemia in Conditions of Increased Oxidative Stress

  2009cited by this paper
• Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation

  2008cited by this paper
• Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

  2008cited by this paper
• Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

  2008cited by this paper
• Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration‐independent mechanism in endothelial cells

  2007cited by this paper
• Hyperoxia inhibits several critical aspects of vascular development

  2007cited by this paper
• A Specific Role for eNOS-Derived Reactive Oxygen Species in Atherosclerosis Progression

  2007cited by this paper
• A VEGF165-induced phenotypic switch from increased vessel density to increased vessel diameter and increased endothelial NOS activity.

  2006cited by this paper
• NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.

  2006cited by this paper
• Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique.

  2005cited by this paper
• Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration

  2005cited by this paper
• Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1–dependent microvascular degeneration

  2005cited by this paper
• Stoichiometric Relationships Between Endothelial Tetrahydrobiopterin, Endothelial NO Synthase (eNOS) Activity, and eNOS Coupling in Vivo: Insights From Transgenic Mice With Endothelial-Targeted GTP Cyclohydrolase 1 and eNOS Overexpression

  2005cited by this paper
• Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.

  2005cited by this paper
• NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels.

  2005cited by this paper
• New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy.

  2005cited by this paper
• Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.

  2005cited by this paper
• Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells.

  2004cited by this paper
• Angiogenesis Induced by Endothelial Nitric Oxide Synthase Gene Through Vascular Endothelial Growth Factor Expression in a Rat Hindlimb Ischemia Model

  2003cited by this paper
• Enhancement of Ischemia-Induced Angiogenesis by eNOS Overexpression

  2003cited by this paper
• Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice.

  2003cited by this paper
• Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.

  2002cited by this paper
• Nitric oxide is proangiogenic in the retina and choroid *

  2002cited by this paper
• Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.

  2002cited by this paper
• Reduction of Blood Pressure, Plasma Cholesterol, and Atherosclerosis by Elevated Endothelial Nitric Oxide*

  2002cited by this paper
• Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

  2001cited by this paper
• Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy.

  2001cited by this paper
• Endothelial Regulation of Vasomotion in ApoE-Deficient Mice: Implications for Interactions Between Peroxynitrite and Tetrahydrobiopterin

  2001cited by this paper
• JCB Article

  2001cited by this paper
• Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.

  2001cited by this paper
• Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.

  2000cited by this paper
• Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

  1999cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• Role of endothelial nitric oxide synthase in endothelial cell migration.

  1999cited by this paper
• Superoxide Generation from Endothelial Nitric-oxide Synthase

  1998cited by this paper
• Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin

  1997cited by this paper
• Reciprocal Regulation of Endothelial Nitric-oxide Synthase by Ca2+-Calmodulin and Caveolin*

  1997cited by this paper
• Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.

  1997cited by this paper
• Direct Interaction of Endothelial Nitric-oxide Synthase and Caveolin-1 Inhibits Synthase Activity*

  1997cited by this paper
• Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

  1997cited by this paper
• Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling.

  1996cited by this paper
• Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

  1995cited by this paper
• The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis.

  1995cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

  1995cited by this paper
• Oxygen-induced retinopathy in the mouse.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper

• Citrulline Plus Arginine Induces an Angiogenic Response and Increases Permeability in Retinal Endothelial Cells via Nitric Oxide Production

  2025cites this paper
• Physiological and Pathophysiological Relevance of Nitric Oxide Synthases (NOS) in Retinal Blood Vessels.

  2024cites this paper
• BH4 supplementation reduces retinal cell death in ischaemic retinopathy

  2023cites this paper
• Effect of maternal pregestational diabetes mellitus on congenital heart diseases

  2022cites this paper
• eNOS controls angiogenic sprouting and retinal neovascularization through the regulation of endothelial cell polarity

  2021cites this paper
• eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin

  2020cites this paper
• PPAR-γ Mediates Ta-VNS-Induced Angiogenesis and Subsequent Functional Recovery after Experimental Stroke in Rats

  2020cites this paper
• Microfluidic Device for the Analysis of Angiogenic Sprouting under Bidirectional Biochemical Gradients

  2020cites this paper
• Retinal arteriole reactivity in mice lacking the endothelial nitric oxide synthase (eNOS) gene

  2019cites this paper
• Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy

  2018cites this paper
• BH4-Mediated Enhancement of Endothelial Nitric Oxide Synthase Activity Reduces Hyperoxia-Induced Endothelial Damage and Preserves Vascular Integrity in the Neonate

  2017influential citation
• The Vasoproliferative Phase in the Oxygen-Induced Rat Model ofRetinopathy of Prematurity Exhibits Concomitant Increased Expression ofVEGF164 and Phosphorylation of eNOS at Serine1179.

  2017cites this paper
• Tetrahydrobiopterin (BH4) deficiency is associated with augmented inflammation and microvascular degeneration in the retina

  2017cites this paper
• Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches

  2017cites this paper
• eNOS plays an important role in the regulation of colonic inflammation: A novel therapeutic target and a predictive marker for the prognosis of ulcerative colitis

  2015cites this paper
• Hyperoxia depletes (6R)-5,6,7,8-tetrahydrobiopterin levels in the neonatal retina: implications for nitric oxide synthase function in retinopathy.

  2015cites this paper
• IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels

  2015cites this paper
• Arginase 2 Deficiency Prevents Oxidative Stress and Limits Hyperoxia-Induced Retinal Vascular Degeneration

  2014cites this paper
• CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity.

  2014cites this paper
• Mimicking microvascular alterations of human diabetic retinopathy: a challenge for the mouse models.

  2013cites this paper
• Nitro-oxidative Mechanism and Therapeutic Potential in Diabetic Retinopathy

  year unknowncites this paper